Mongolia
FACULTY
Dr. R.V. Paul Chan is The John H. Panton Professor of Ophthalmology at the Illinois Eye and Ear Infirmary, as well as Director of Pediatric Retina and Retinopathy of Prematurity Service, and Co-Director of the Vitreoretinal Fellowship Program. His clinical practice focuses on vitreoretinal surgery, with an expertise in pediatric retinal disease.
Dr. Chan is also the Vice Chair for Global Ophthalmology at the IEEI; he is committed to global health initiatives with a focus on both surgical training and education for the diagnosis and management of adult and pediatric retinal disease. Dr. Chan’s primary research interests focus on utilizing new technology and imaging techniques to better evaluate and manage pediatric retinal disease. He receives grant funding from the NIH as well as a number of charitable foundations. He is a core team member of the Imaging and Informatics for ROP (i-ROP) consortium and leads the Global Education Network for ROP (GEN-ROP), which is an international collaboration of investigators with expertise in neonatology, ophthalmology, biomedical informatics, international health, and medical education. Together, they are implementing tele-education programs aimed at addressing the growing global burden of ROP and have established clinical, teaching, and research collaborations in Asia, Latin America, and Africa. Dr. Chan also serves as a consultant for both Orbis International and Helen Keller International (HKI), and sits on the Board of Trustees for HKI.
FACULTY
Dr. R.V. Paul Chan is The John H. Panton Professor of Ophthalmology at the Illinois Eye and Ear Infirmary, as well as Director of Pediatric Retina and Retinopathy of Prematurity Service, and Co-Director of the Vitreoretinal Fellowship Program. His clinical practice focuses on vitreoretinal surgery, with an expertise in pediatric retinal disease.
Dr. Chan is also the Vice Chair for Global Ophthalmology at the IEEI; he is committed to global health initiatives with a focus on both surgical training and education for the diagnosis and management of adult and pediatric retinal disease. Dr. Chan’s primary research interests focus on utilizing new technology and imaging techniques to better evaluate and manage pediatric retinal disease. He receives grant funding from the NIH as well as a number of charitable foundations. He is a core team member of the Imaging and Informatics for ROP (i-ROP) consortium and leads the Global Education Network for ROP (GEN-ROP), which is an international collaboration of investigators with expertise in neonatology, ophthalmology, biomedical informatics, international health, and medical education. Together, they are implementing tele-education programs aimed at addressing the growing global burden of ROP and have established clinical, teaching, and research collaborations in Asia, Latin America, and Africa. Dr. Chan also serves as a consultant for both Orbis International and Helen Keller International (HKI), and sits on the Board of Trustees for HKI.
PROJECTS
In collaboration with Orbis International, the National Center for Maternal and Child Health (NCMCH) in Ulaanbaatar, Mongolia, and the Global Education Network for Retinopathy of Prematurity (GEN-ROP) the first ROP screening and management program in Mongolia was established. Dr. R.V. Paul Chan and his team lead GEN-ROP, who worked with local partners in developing, implementing, and validating the screening and training program for retinopathy of prematurity. The major goal of this project is to build the capacity in Mongolia to train, issue equipment, and develop monitoring systems that will allow for more sustainable and scalable models for pediatric eye care. Support was provided by the United States Agency for International Development (USAID) Child Blindness Program.
PROJECTS
In collaboration with Orbis International, the National Center for Maternal and Child Health (NCMCH) in Ulaanbaatar, Mongolia, and the Global Education Network for Retinopathy of Prematurity (GEN-ROP) the first ROP screening and management program in Mongolia was established. Dr. R.V. Paul Chan and his team lead GEN-ROP, who worked with local partners in developing, implementing, and validating the screening and training program for retinopathy of prematurity. The major goal of this project is to build the capacity in Mongolia to train, issue equipment, and develop monitoring systems that will allow for more sustainable and scalable models for pediatric eye care. Support was provided by the United States Agency for International Development (USAID) Child Blindness Program.